| Title |
The cognitive impact of anticholinergics: A clinical review
|
|---|---|
| Published in |
Clinical Interventions in Aging, May 2009
|
| DOI | 10.2147/cia.s5358 |
| Pubmed ID | |
| Authors |
Noll Campbell, Malaz Boustani, Tony Limbil, Carol Ott, Chris Fox, Ian Maidment, Cathy C Schubert, Stephanie Munger, Donna Fick, David Miller, Rajesh Gulati |
| Abstract |
The cognitive side effects of medications with anticholinergic activity have been documented among older adults in a variety of clinical settings. However, there has been no systematic confirmation that acute or chronic prescribing of such medications lead to transient or permanent adverse cognitive outcomes. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 38% |
| Canada | 1 | 13% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 63% |
| Practitioners (doctors, other healthcare professionals) | 2 | 25% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 275 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | <1% |
| Netherlands | 1 | <1% |
| Brazil | 1 | <1% |
| Germany | 1 | <1% |
| India | 1 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 266 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 43 | 16% |
| Student > Master | 33 | 12% |
| Other | 32 | 12% |
| Student > Ph. D. Student | 31 | 11% |
| Student > Postgraduate | 20 | 7% |
| Other | 56 | 20% |
| Unknown | 60 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 104 | 38% |
| Psychology | 22 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 7% |
| Neuroscience | 16 | 6% |
| Nursing and Health Professions | 11 | 4% |
| Other | 25 | 9% |
| Unknown | 77 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 104. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2020.
All research outputs
#413,261
of 26,017,215 outputs
Outputs from Clinical Interventions in Aging
#37
of 1,986 outputs
Outputs of similar age
#886
of 108,017 outputs
Outputs of similar age from Clinical Interventions in Aging
#1
of 11 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,986 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,017 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.